Rtw Investments, LP Tango Therapeutics, Inc. Transaction History

Rtw Investments, LP

  • $6.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$6.52 - $12.01 $12.8 Million - $23.6 Million
1,966,752 New
1,966,752 $19.5 Million
Q1 2022

May 16, 2022
SELL
$7.01 - $10.94 $1.27 Million - $1.98 Million
-180,819 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$9.55 - $14.29 $4 Million - $5.99 Million
-419,181 Reduced 69.86%
180,819 $1.98 Million
Q3 2021

Nov 15, 2021
BUY
$9.56 - $17.3 $5.74 Million - $10.4 Million
600,000 New
600,000 $7.76 Million

Others Institutions Holding TNGX

# of Institutions
123
Shares Held
91.7M
Call Options Held
3.1K
Put Options Held
1.5K
View Full List

About Tango Therapeutics, Inc.

TNGX Quotes by TradingView
  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $359M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email